| Mrs Bridget Nicole Stewart, MA, AADC, MAC, SAP | |
|
642 Brady St, Barboursville, WV 25504-1340 | |
| (681) 886-1036 | |
| Not Available |
| Full Name | Mrs Bridget Nicole Stewart |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 642 Brady St, Barboursville, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235664350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Bridget Nicole Stewart, MA, AADC, MAC, SAP 3085 Martha Rd, Barboursville, WV 25504-9438 Ph: (681) 886-1036 | Mrs Bridget Nicole Stewart, MA, AADC, MAC, SAP 642 Brady St, Barboursville, WV 25504-1340 Ph: (681) 886-1036 |
News Archive
A new class of drugs that inhibits a "master switch" involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
Suicide is the leading cause of non-accidental death in Ontario's youths aged 10 to 19, claiming the lives of our young people more than any other health-related cause. Mental illness is the strongest risk factor for suicide yet these youths cannot get treatment because of years of government underfunding.
Cancer Research UK has launched a major new clinical trial for the most common form of lung cancer, to test the effectiveness of one of the new generation of 'smart' cancer drugs as a first line treatment.
Research performed at the Center of Research and Advanced Studies (Cinvestav) has identified that certain food and lifestyle habits can turn on or off the expression of cancer related genes.
› Verified 8 days ago
Sharla Meade, LPC Counselor Medicare: Medicare Enrolled Practice Location: 3450 Us Route 60 E, Barboursville, WV 25504 Phone: 304-955-6300 Fax: 304-733-5903 | |
Tyler R Burns, MA, LPC, AADC, NCC Counselor Medicare: Medicare Enrolled Practice Location: 6171 Childers Rd, Barboursville, WV 25504 Phone: 304-733-5380 Fax: 304-733-5796 | |
Joshua Parker, LPN Counselor Medicare: Not Enrolled in Medicare Practice Location: 3014 Champion Dr, Barboursville, WV 25504 Phone: 740-479-0067 Fax: 304-900-3629 | |
Jean Culbertson Sutton, M.DIV. Counselor Medicare: Not Enrolled in Medicare Practice Location: 701 Main St, Barboursville, WV 25504 Phone: 304-654-4213 | |
Kathryn Black, M.ED., NCC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 642 Brady St, Barboursville, WV 25504 Phone: 304-733-1833 | |
Lola I Toney, COUNSELOR Counselor Medicare: Not Enrolled in Medicare Practice Location: 6171 Childers Rd Ste 101, Barboursville, WV 25504 Phone: 304-733-5380 Fax: 304-733-5796 |